Rosuvastatin, widely recognized under the brand name Crestor, is a leading medication for managing cholesterol levels and reducing the risk of cardiovascular events. Developed by AstraZeneca, Rosuvastatin is a powerful statin that works by inhibiting HMG-CoA reductase, an enzyme critical in the production of cholesterol in the liver. This action helps lower LDL cholesterol (often referred to as “bad” cholesterol) and triglycerides while increasing HDL cholesterol (“good” cholesterol). Rosuvastatin’s proven efficacy and robust safety profile have made it a trusted choice for patients with hyperlipidemia and those at high risk of heart disease. AstraZeneca’s commitment to innovation and patient-centered care ensures that Rosuvastatin provides effective, reliable treatment for maintaining cardiovascular health and preventing serious complications associated with high cholesterol.